🇺🇸 FDA
Patent

US 12144802

Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug

granted A61KA61K31/44A61K47/10

Quick answer

US patent 12144802 (Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCUTIS BIOTHERAPEUTICS, INC.
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/44, A61K47/10, A61K47/14, A61K47/22